Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04988009 · ClinicalTrials.gov registry record
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
A clinical trial of Metastatic Malignant Neoplasm in the Brain and Central Nervous System Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04988009: Recruiting study of Metastatic Malignant Neoplasm in the Brain and Central Nervous System Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT04988009 is a study of Metastatic Malignant Neoplasm in the Brain and Central Nervous System Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 200 participants, above the 83-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (141% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04988009, a study of Metastatic Malignant Neoplasm in the Brain and Central Nervous System Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.
Primary Outcome
Survey responses will be summarized by ordinal category as counts with percentages, separately by group. Will separately estimate the proportion of each ordinal level of each group with 95% confidence interval.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Electronic Health Record Review
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-08-20 |
| Est. Completion | 2026-12-31 |
What NCT04988009 shows while recruiting
NCT04988009 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 83-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (141% higher).
The record links to 4 conditions, with Metastatic Malignant Neoplasm in the Brain appearing as the primary indexed condition, and to 2 interventions - of which Survey Administration is the first listed.
NCT04988009 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04988009 about?
NCT04988009 is a clinical study titled "Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology". This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.
What is the current status of trial NCT04988009?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2020-08-20. Estimated completion is 2026-12-31.
What conditions does trial NCT04988009 study?
This clinical trial studies the following conditions: Metastatic Malignant Neoplasm in the Brain, Central Nervous System Neoplasm, Leptomeningeal Neoplasm, Primary Brain Neoplasm.
What interventions are being tested in trial NCT04988009?
The interventions under investigation include: Survey Administration (OTHER), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT04988009?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04988009 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Neoplasm in the Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04988009's enrollment target sits among peer trials
200 5th of 43 higher than 38 of 43 other Metastatic Malignant Neoplasm in the Brain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metastatic Malignant Neoplasm in the Brain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
RECRUITING · Phase 3
-
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
RECRUITING · Phase 1
-
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
RECRUITING · NA
-
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
RECRUITING · NA
-
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
RECRUITING · Phase 1
-
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI